In 1675, Sir Isaac Newton wrote:
"If I have seen further it is by standing
on the shoulders of giants."
In developing each mEYE® report we are relying on research conducted over many decades by thousands of researchers worldwide. Over 30,000 research papers on myopia alone are listed on PubMed®, the world’s largest medical science database.
Harnessing advanced data science tools, Ocumetra translates findings from peer-reviewed research, incorporating over a million data points on refractive development, eye growth, myopia-related eye disease, and vision impairment to craft highly personalized mEYE reports for each child examined.
Moore M, Loughman J, Butler JS, et al. Application of big-data for epidemiological studies of refractive error. PLoS One; 16. Epub ahead of print 1 April 2021. DOI: 10.1371/JOURNAL.PONE.0250468.
Loughman J, Moore M, Flitcroft DI. Myopia Progression Centiles from Real World Data: An Ecologically Valid Tool for Myopia Treatment Efficacy Monitoring?. Invest. Ophthalmol. Vis. Sci. 2020;61(7):79.
Polling JR, Klaver C, Tideman JW. Myopia progression from wearing first glasses to adult age: the DREAM Study. Br J Ophthalmol 2021; bjophthalmol-2020-316234.
He M, Ge J, Zheng Y, Huang W, Zeng J (2006) The Guangzhou Twin Project. Twin Res Hum Genet 9: 753–757.
Zhou WJ, Zhang YY, Li H, et al. Five-year progression of refractive errors and incidence of myopia in school-aged children in Western China. J Epidemiol 2016; 26: 386–395.
Guo Y, Liu LJ, Tang P, et al. Outdoor activity and myopia progression in 4-year follow-up of Chinese primary school children: The Beijing Children Eye Study. PLoS One; 12. DOI: 10.1371/journal.pone.0175921.
Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis. Ophthalmology 2016; 123: 697–708.
Chamberlain P, Peixoto-de-Matos SC, Logan NS, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci 2019; 96: 556–567.
Flitcroft D.I, Loughman, Arumugam B, Bradley A, Chamberlain P. Centile-based analysis of refractive development in the MiSight® 1 day Myopia Control trial.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1372.
Bao J, Huang Y, Li X, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022;140(5):472–478. doi:10.1001/jamaophthalmol.2022.0401
Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The Risks and Benefits of Myopia Control. Ophthalmology 2021; 128(11):1561-1579.
Tideman JWL, Snabel MCC, Tedja MS, et al. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol 2016; 134: 1355.
Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a Rural Population of Southern India: The Aravind Comprehensive Eye Survey. Ophthalmology 2003;110:1484-90.
Pan CW, Cheung CY, Aung T, et al. Differential Associations of Myopia with Major Age-Related Eye Diseases: The Singapore Indian Eye Study. Ophthalmology 2013;120:284-91.
Xu L, Wang Y, Wang S, et al. High Myopia and Glaucoma Susceptibility the Beijing Eye Study. Ophthalmology 2007;114:216-20.
Chon B, Qiu M, Lin SC. Myopia and Glaucoma in the South Korean Population. Invest Ophthalmol Vis Sci 2013;54:6570-7.
Qiu M, Wang SY, Singh K, Lin SC. Association between Myopia and Glaucoma in the United States Population. Invest Ophthalmol Vis Sci 2013;54:830.
Shen L, Melles RB, Metlapally R, et al. The Association of Refractive Error with Glaucoma in a Multiethnic Population. Ophthalmology 2016;123:92-101.
Grødum K, Heijl A, Bengtsson BB. Refractive error and glaucoma. Acta Ophthalmol Scand 2001; 79: 560–566.
Wong TY, Foster PJ, Johnson GJ, Seah SK. Refractive Errors, Axial Ocular Dimensions, and Age-Related Cataracts: The Tanjong Pagar Survey. Invest Ophthalmol Vis Sci 2003;44:1479-85.
Wong TY, Klein BE, Klein R, et al. Refractive Errors and Incident Cataracts: The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2001;42:1449-54.
Chang MA, Congdon NG, Bykhovskaya I, et al. The Association between Myopia and Various Subtypes of Lens Opacity: See (Salisbury Eye Evaluation) Project. Ophthalmology 2005;112:1395-401.
Ogawa A, Tanaka M. The Relationship between Refractive Errors and Retinal Detachment–Analysis of 1,166 Retinal Detachment Cases. Jpn J Ophthalmol 1988;32:310-5.
Zou H, Zhang X, Xu X, et al. Epidemiology Survey of Rhegmatogenous Retinal Detachment in Beixinjing District, Shanghai, China. Retina 2002;22:294-9.
Risk Factors for Idiopathic Rhegmatogenous Retinal Detachment. The Eye Disease Case-Control Study Group. Am J Epidemiol 1993;137:749-57.
Bohringer HR. Statistics on the Frequency and Risks on Retinal Detachment. Ophthalmologica 1956;131:331-4.
Perkins ES. Morbidity from Myopia. Sight Sav Rev 1979;49:11-9.
Burton TC. The Influence of Refractive Error and Lattice Degeneration on the Incidence of Retinal Detachment. Trans Am Ophthalmol Soc 1989;87:143-55; discussion 55-7.
Mitry D, Charteris DG, Yorston D, et al. The Epidemiology and Socioeconomic Associations of Retinal Detachment in Scotland: A Two-Year Prospective Population-Based Study. Invest Ophthalmol Vis Sci 2010;51:4963-8.
Liu HH, Xu L, Wang YX, et al. Prevalence and Progression of Myopic Retinopathy in Chinese Adults: The Beijing Eye Study. Ophthalmology 2010;117:1763-8.
Centile charts have been a standard part of monitoring children’s height and weight for over a 100 years and their application to monitor spectacle prescription and eye growth uses the same principles.
This part of the tool simulates expected vision quality with either glasses/contact lenses and without glasses/contact lenses (uncorrected vision). While a myopic child’s vision with glasses/contact lenses should remain good, their uncorrected vision will worsen with increasing myopia. At low levels of myopia, preserving uncorrected vision quality is one of the goals of treatment to ensure a child is less dependent on their glasses/contact lenses for daily life.
All available myopia management options have been tested in clinical trials comparing them to conventional single vision glasses. We express the benefits of these treatments in terms of the probability of significant changes in glasses strength. For lower levels of myopia, we assess the risk of developing related eye diseases, and for higher levels, the risk of future visual impairment. The benefits are based on average reported outcomes from current treatments.
New options and insights into treatment effectiveness can change fairly quickly as research continues to grow. We consistently review new evidence regarding treatments including how well they work and incorporate that information if necessary into each report. Your link or QR-code will always show the most up to date treatment information.
A vast amount of research has looked at how our behaviour and lifestyle growing up, affects our eyes. We have tried to distill this into the most important messages, that can help to not only delay the onset of myopia in children but also maximize how well their chosen treatment could work for them.
For a complete list of references used in the development of our tools, please get in touch at info@ocumetra.com
We use cookies to improve your browsing experience. By clicking “Allow all”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. You can modify your cookie preferences by clicking on "Set Preferences" option below.
Opticians
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.